ARCHIVES

Duke Scores Highest On NCAB Review

This article is from The Cancer Letter archive.

Vol. 04 No. 28 | July 14, 1978

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010

Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.

September 28, 2001

The Lancet Corrects Henschke Letters.

July 18, 2008